Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy

Psychosomatics

Volumn 37, Issue 2, 1996, Pages 165-166

  Rone, L A ^a   Ferrando, S J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; CASE REPORT; CEREBRAL PALSY; DEPRESSION; DRUG MECHANISM; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERREFLEXIA; LETTER; MUSCLE HYPERTONIA; SPASTICITY;

EID: 0030021190     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(96)71586-4     Document Type: Letter

References (7)

1. D.M. Coulter P.I. Pillans Fluoxetine and extrapyramidal side effects Am J Psychiatry 152 1995 122 125
2. R.H. Bouchard E. Pourcher P. Vincent Fluoxetine and extrapyramidal side effects Am J Psychiatry 146 1989 1352 1353
3. V. Choo Paroxetine and extrapyramidal reactions Lancet 341 1993 624
4. J.F. Lipinski G. Mallya P. Zimmerman Fluoxetine induced akathisia: clinical and theoretical implications J Clin Psychiatry 50 1989 339 342
5. E.N. Steur Increase of Parkinson disability after fluoxetine medication Neurology 43 1993 211 213
6. K. Rickels E. Schweizer Clinical overview of serotonin reuptake inhibitors J Clin Psychiatry 51 1990 9 12
7. L Rowland Merritt's Textbook of Neurology 1989 Lea and Febiger Philadelphia 458 465